A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...

GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...

Early-stage study results suggest that a single shot of the company’s therapy, which works differently than GLP-1 medicines, ...

A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...

Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.

Orforglipron (pronounced or-for-GLIP-ron) might be a mouthful to say, but Indianapolis-based Eli Lilly and Co. sees this ...

Weight-loss drugs are already dropping in price; could they go even lower? - Consumers are now able to pay roughly $500 for ...

Eli Lilly and Company has emerged as a pharmaceutical powerhouse, riding an unprecedented wave of success in the GLP-1 market (Mounjaro and Zepbound) that is reshaping both the company and the broader ...

Health experts are raising concerns for women using popular weight loss medications, particularly GLP-1s like Wegovy, ...

Are you weening yourself off a compounded version of the drug? Considering switching insurers in order to keep your ...

The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...